Abstract:Chronic hepatitis B virus (HBV) infection is characterized by functionally impaired type 1 T-helper cell (Th1) immunity and poor HBV-specific T-cell responses. Ubiquitin (Ub), a highly conserved small regulatory protein, commonly serves as a signal for target proteins that are recognized and degraded in proteasomes. The rapid degradation of Ub-mediated antigens results in efficient stimulation of cell-mediated immune responses. Thus, the Ub-HBV core antigen (HBcAg)-cytoplasmic transduction peptide (CTP) fusion protein was designed for specific delivery of a foreign modified antigen to the cytoplasm of antigen-presenting cells. HBV transgenic mice were used to determine whether Ub-HBcAg-CTP would restore HBV-specific immune responses and anti-viral immunity in these animals. The results demonstrated that synthesized Ub-HBcAg-CTP not only significantly increased the levels of interleukin-2 and interferon (IFN)-gamma compared with those in the HBcAg-CTP, IFN-alpha, Ub-HBcAg, HBcAg and phosphate-buffered saline groups, but additionally induced the highest IFN-gamma(+) CD8(+) T-cell numbers and HBV-specific cytotoxic T lymphocyte (CTL) responses, indicating a strong immune response. In addition, enhancement of specific CTL activity provoked by the fusion protein reduced hepatitis B surface antigen (HBsAg) and HBV DNA serum levels and diminished the expression of HBsAg and HBcAg in liver tissue of HBV transgenic mice, suggesting that there was a therapeutic effect. In conclusion, the present study provided evidence that Ub-HBcAg-CTP activated the Th1-dependent immunity, triggered functional T cell responses and subsequently inhibited viral replication in HBV transgenic mice. These observations suggested that the fusion protein may represent an innovative and promising candidate for active immunotherapy during chronic and persistent HBV.

Intracellular-Delivery Of A Single-Chain Antibody Against Hepatitis B Core Protein Via Cell-Penetrating Peptide Inhibits Hepatitis B Virus Replication In Vitro

Artificial Recombinant Cell-Penetrating Peptides Interfere with Envelopment of Hepatitis B Virus Nucleocapsid and Viral Production.

Transbody Against Hepatitis B Virus Core Protein Inhibits Hepatitis B Virus Replication in Vitro.

An E. Coli-Produced Single-Chain Variable Fragment (scfv) Targeting Hepatitis B Virus Surface Protein Potently Inhibited Virion Secretion.

Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice

An Aptamer Targets Hbv Core Protein And Suppresses Hbv Replication In Hepg2.2.15 Cells

Prokaryotic Expression of a Novel Therapeutic recombinant transbody H2L2 Targeting Hepatitis B Virus core protein

Inhibition of Hepatitis B Virus Replication by the Internal Fragment of Hepatitis B Core Protein.

Ubiquitin-Hepatitis B Core Antigen-Cytoplasmic Transduction Peptide Enhances Hbv-Specific Humoral and Ctl Immune Responses in Vivo

Ubiquitin-modified hepatitis B virus core antigen effectively facilitates antigen presentation and enhances cytotoxic T lymphocyte activity via the cytoplasmic transduction peptide in vitro.

Study on the Inhibition of Hepatitis B Virus by Single-chain Fv Fragment

Towards Cell-Permeable Hepatitis B Virus Core Protein Variants as Potential Antiviral Agents

The Delivery of HBcAg Via Tat-PTD Enhances Specific Immune Response and Inhibits Hepatitis B Virus Replication in Transgenic Mice.

The fusion protein of cytoplasmic transduction peptide (CTP)-HBcAg18-27-Tapasin enhances specific immune response to hepatitis B virus and inhibits viral replication in transgenic mice

A Bispecific Antibody Against Two Different Epitopes on Hepatitis B Surface Antigen Has Potent Hepatitis B Virus Neutralizing Activity.

Targeted Delivery of Interferon-Α to Hepatitis B Virus-Infected Cells Using T-cell Receptor-Like Antibodies.

HBx-Derived Constrained Peptides Inhibit the Secretion of Hepatitis B Virus Antigens

Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase

Induction of Hepatitis B Core Protein Aggregation Targeting an Unconventional Binding Site

Transbody Against Virus Core Protein Potently Inhibits Hepadnavirus Replication in Vivo: Evidence from A Duck Model of Hepatitis B Virus

Chimeric Antigen Receptors of HBV Envelope Proteins Inhibit Hepatitis B Surface Antigen Secretion.